BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Mar 06, 09:00Prev. Close
18.16
Open Price
18.16
Bid Price (Qty.)
18.16 (410)
Offer Price (Qty.)
18.16 (49)
| Cash Flow of Balaxi Pharmaceuticals (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 9.27 | 2.44 | -0.77 | -0.79 | -0.12 | |
| Net CashFlow From Operating Activities | -14.37 | -1.51 | -0.68 | -0.99 | -0.12 | |
| Net Cash Used In Investing Activities | -0.28 | -0.01 | -0.01 | 3.29 | 0.00 | |
| Net Cash Used From Financing Activities | 18.10 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 3.44 | -1.51 | -0.69 | 2.30 | -0.12 | |
| Cash And Cash Equivalents Begin of Year | 0.10 | 1.62 | 2.30 | 0.01 | 0.02 | |
| Cash And Cash Equivalents End Of Year | 3.55 | 0.10 | 1.62 | 2.30 | -0.10 |
29.01.2026
Balaxi Pharma Consolidated December 2025 Net Sales at Rs 72.54 crore, down 1.02% Y-o-Y
29.01.2026
Balaxi Pharma Standalone December 2025 Net Sales at Rs 24.59 crore, up 120.41% Y-o-Y
19.11.2025
Balaxi Pharma Consolidated September 2025 Net Sales at Rs 56.18 crore, down 27.41% Y-o-Y
18.11.2025
Balaxi Pharma Standalone September 2025 Net Sales at Rs 19.31 crore, down 8.72% Y-o-Y
29.01.2026
Balaxi Pharma Consolidated December 2025 Net Sales at Rs 72.54 crore, down 1.02% Y-o-Y
29.01.2026
Balaxi Pharma Standalone December 2025 Net Sales at Rs 24.59 crore, up 120.41% Y-o-Y
19.11.2025
Balaxi Pharma Consolidated September 2025 Net Sales at Rs 56.18 crore, down 27.41% Y-o-Y
18.11.2025
Balaxi Pharma Standalone September 2025 Net Sales at Rs 19.31 crore, down 8.72% Y-o-Y
15.06.2017
24.04.2017
18.04.2017
18.04.2017
14.02.2017
13.02.2017
12.02.2017
09.12.2016